In the previous study we reported that decreases in concentrations of phosphatidylglycerol, pulmonary surfactant protein A (SP-A
Pulmonary surfactant is a complex mixture of phospholipids and proteins that are synthesized by alveolar type II cells [1, 15] and keep the alveoli from collapsing at the end of expiration. Four proteins obtained from lavages of several species, including horses, canine, human beings, cows and mice [4, 5, 10-12, 16, 17] have been identified which are lung-specific and associated with surfactant. Results of studies [6] [7] [8] [9] indicate that measurement of pulmonary surfactant proteins in the bronchoalveolar lavage fluid (BALF) or serum is useful in the diagnosis of lung diseases. Evaluation of pulmonary surfactant from the alveolar area that has escaped into the blood is potentially useful as a clinical tool for diagnosis of pulmonary conditions [8, 9, 13, 18] .
Development of respiratory tract disease in horses has been associated with transportation over long distances [3, 14] . Major potential contributing factors for the development of respiratory tract diseases during transportation include stress, suppression of immune function, increased environmental irritants, aggravation of pre-existing respiratory tract disease, and compromised pulmonary defense mechanisms. In a previous study [3, 6] , we reported that decreases in concentrations of phosphatidylglycerol, pulmonary surfactant protein A (SP-A), and pulmonary surfactant protein D (SP-D) in BALF of horses after transportation indicated a reduction in the quantity of surfactant in the lungs. However, it is unknown whether SP-A This article was accepted March 12, 2004 *Corresponding author. e-mail: hobo@epizoo.equinst.go.jp concentration in serum changes during transportation, as might be expected if SP-A were leaking from the alveoli into pulmonary capillary blood.
The purpose of the study reported here was to develop a 2-site sandwich ELISA for detection of SP-A in serum of horses and determine whether serum SP-A concentrations change during transportation of horses.
Materials and Methods
Horses and sample collection-In this study, we used horses that were used in previous studies [2] [3] [4] [5] [6] . The Animal Use and Care Committee and Animal Welfare and Ethics Committee of the Equine Research Institute, Japan Racing Association, approved protocols for this study.
Details regarding the transportation of the horses have been previously described [3] . Briefly, 25 Thoroughbreds without a history or clinical signs of respiratory tract disease (12 males, 13 females; 27 to 30 months old) were allocated into 2 groups. Horses in group 1 (control, n=5) remained in the stable for the duration of the study. Horses in group 2 (n=20) were transported by trucks for 41 hr, with a 1 hr rest period after every 5 hr. All horses had access freely to hay and water during transportation on the trucks and during the 1 hr rest period. Trucks exclusively designed for the transportation of horses were used. Horses were loaded 4 to a truck. Each truck was designed to carry 6 horses separated by partitions. Halters and ropes secured the horses' heads. The windows of the trucks were opened during transportation and during the 1 hr rest period. Blood samples were collected from the left jugular vein from all horses at time 0, and at 5, 11, 17, 23, 29, 35 and 41 hr. Blood samples were centrifuged (2,000 × g, for 10 min at 4°C) to separate cell components from serum within 1 hr after the samples were obtained. Serum samples were stored at -80°C until analyzed. Concentrations of SP-A in serum were measured by use of a 2-site sandwich ELISA. Rectal temperature of all horses of this study was measured at time 0, and at 2.5, 5, 8.5, 11, 14.5, 17, 20.5, 23, 26.5, 29, 32.5, 35, 38.5, and 41 hr at stopped condition of truck during transportation. We measured the rectal temperature for control horses at same time to transported horses.
Development of 2-site sandwich ELISA for SP-A in serum of horses-Monoclonal antibodies (mAb) against SP-A were developed by use of methods described previously [6] .
The optimal concentration of Triton X-100 was determined by testing various concentrations of Triton X-100 with a 2-site sandwich ELISA. Concentrations of Triton X-100 that were tested included 0, 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, or 4.0 % (v/v). Sera from 2 horses with and without pyrexia were used. Three replicates were determined for each concentration of Triton X-100.
Within-run and between-run variations for precision of the ELISA were assessed by assaying 10 replicates of 3 samples of serum from study horses (2 with and 1 without pyrexia). Within-run is 10 replicates of 3 samples in same assay. Between-run is 10 replicates of 3 samples on 10 deferent days. Mean ± SD, and coefficient of variation (CV) were calculated for each sample.
To assess the accuracy of the ELISA for determining the concentration of SP-A in serum, 50, 100, and 200 ng of equine SP-A/ml were added to 3 samples of serum from study horses (2 with and 1 without pyrexia). The 2-site sandwich ELISA measured the concentration of SP-A in each sample and percentage recovery was calculated for each sample. Ten replicates were determined for each sample.
Statistical analyses-Data are expressed as mean ± SD. Within each group, data were analyzed with the paired t test to determine whether there were significant differences between the concentration of SP-A obtained at time 0 and at 6 hr before the detection of pyrexia or the maximum SP-A concentration. Pearson's correlation coefficient was used to assess the association between the maximum rectal temperature and the duration of pyrexia in transported horses, the duration of pyrexia in transported horses and the maximum concentration of SP-A in serum of transported horses, and the maximum rectal temperature and the maximum concentration of SP-A in serum of transported horses. A value of P<0.05 was considered significant.
Results
The concentration of SP-A in serum was determined by use of optimal assay conditions. Maximum values for SP-A in the serum samples were obtained when 3% (v/ v) Triton X-100 incubated at a reaction temperature of 37°C were used. This concentration of Triton X-100 and 37°C were used in subsequent assays, and was capable of detecting 0.78 to 100 ng of SP-A/ml of serum. The ELISA had good intra-assay precision, with a CV of 2.2 to 3.0% for the within-run assay, and 3.0 to 4.7% for the between-run assay ( Table 1 ). Recovery of SP-A added to serum was 98.3 to 103.0% (Table 2) .
During transportation, rectal temperatures ≥38.5°C were recorded in 12 of 20 horses in group 2 (39.2 ± 0.6°C; range, 38.6 to 40.1°C). We detected the pyrexia at time 23, 29, 35 and 41 hr during transportation by road. Mean ± SD maximum rectal temperature of 6 horses that remained pyrexia for >10 hr was 39.7 ± 0.4°C. Mean ± SD maximum rectal temperature of 6 horses that were pyrexia for ≤10 hr was 38.7 ± 0.2°C. There was a positive correlation (r=0.891) between the maximum rectal temperatures and the duration of pyrexia (Fig. 1 ). There was a positive correlation (r=0.971) between the maximum concentrations of SP-A in sera and the duration of pyrexia (Fig. 2) . There was a positive correlation (r=0.907) between the maximum concentrations of SP-A in sera and the maximum rectal temperatures. There was no correlation between the number of febrile horses and each truck. There was no pyrexia in horses in group 1. Other clinical signs observed during transportation of horses in this study were similar to clinical signs observed in previous studies [6] .
In febrile horses of group 2, mean ± SD maximum concentration of SP-A in serum was approximately 2.8-fold higher than that at time 0 in those same horses NA=Not applicable. Recovery (ng/ml )=SP-A concentration (ng/ml ) after SP-A added (50, 100 or 200 ng/ml )-SP-A concentration (ng/ml ) after SP-A added (0 ng/ml ). Recovery (%)=Recovery (ng/ml ) at SP-A added (50, 100 or 200 ng/ml) ÷ SP-A added (50, 100 or 200 ng/ml) × 100. For example: Recovery (ng/ml ) at SP-A added (50 ng/ml ) to Serum sample 1=124.5-73.0=51.5 (ng/ml ). Recovery (%) at SP-A added (50 ng/ml ) to Serum sample 1=51.5 ÷ 50.0 × 100=103.0 (%).
( Table 3) . No significant differences were observed between the maximum concentration of SP-A in serum and the concentration of SP-A at time 0 in horses in group 1 (control) or in afebrile horses in group 2. Mean ± SD maximum concentration of SP-A in serum o f 6 h o r s e s t h a t w e r e f e br i l e f o r > 1 0 h r w a s approximately 4.3-fold higher than that at time 0 in those horses (Table 4) . However, mean ± SD maximum concentration of SP-A in serum of 6 horses that were febrile for ≤10 hr was only approximately 28% higher than that at time 0 in those same horses. Mean ± SD concentration of SP-A in serum at 6 hr to the detection of pyrexia in horses in group 2 that became febrile was 15.2 to 52.8% higher than that at time 0 (Table 4) .
Discussion
Evaluation of pulmonary surfactant from the alveolar area that has escaped into the blood is potentially useful as a clinical tool for diagnosis of pulmonary conditions [8, 9, 13, 18] . Therefore, we made murine mAb against pulmonary SP-A in horses, and developed a sandwich ELISA with these mAb to quantitatively assess components of pulmonary surfactant.
Results of our study indicated that a combination of TA08 as a capture antibody and HRP-conjugated WA28 as a detecting antibody provided an optimal ELISA for detection of SP-A in serum from horses. The assay was sensitive and reproducible in the range of 0.78 to 100 ng of SP-A/ml of serum. For higher sensitivity, the assay required Triton X-100 during incubation of the SP-A with monoclonal antibody bound to the surface of beads. Results of our study indicated that Triton X-100 separated SP-A from IgG, because SP-A is composed of IgG and other proteins in the blood [10] .
In the previous study [6] , we reported that concentrations of SP-A and SP-D in BALF in horses decreased significantly after transportation, however, we could not determine the mechanism of this decrease. Results of the present study indicate that the concentration of SP-A in serum increased during transportation in febrile horses. We hypothesized that this increase was caused by leakage of SP-A from the alveolar region into the circulation because of deterioration of the integrity of the alveolar basement membrane. Results of another study [14] suggest that destruction of the alveolar basement membrane may have been caused by infection with Streptococcus equi s u b s p . z o o e p i d e m i c u s . T h e m a x i m u m S P -A concentration in serum of 6 horses that were febrile for >10 hr were higher than that of six horses that were febrile for ≤10 hr. These results suggest that the deterioration of the alveolar basement membrane was more clearly caused in the horses, which generated febrile the long time more. As other reasons of the decrease in SP-A concentration in BALF, it may also be caused by decreased production of surfactant by alveolar type II epithelial cells or increased removal of surfactant from the alveolar region.
In this study, we described changes of SP-A in serum of horses during prolonged transportation by road. The changes of SP-A concentrations in sera at 6 hr to the detection of pyrexia may indicate the possibility of the early detection of generation of pyrexia. Concentrations of SP-A in serum have been measured i n h u m a n s w i t h l u n g d i s e a s e [ 8 , 9 , 1 3 , 1 8 ] . Determination of SP-A concentrations by use of the ELISA developed in this study may be useful for the identification of lung conditions or to monitor the progression of lung disease in horses.
